Please login to the form below
fexofenadine
This page shows the latest fexofenadine news and features for those working in and with pharma, biotech and healthcare.
Hesperos’ ‘human-on-a-chip’ predicts drug toxicity in the lab
in the heart module, as well as model the effect of metabolising the drug to fexofenadine with the addition of the liver module.
Latest news
-
Nasacort approval cements Sanofi's OTC ambitions
Nasacort Allergy 24HR (triamcinolone) is the second allergy product Sanofi has moved from prescription-only to OTC status, after its Allegra (fexofenadine) was switched in 2011.
-
FDA panel backs OTC use of Sanofi's allergy drug
Sanofi has already won OTC approval for another allergy drug, with Allegra (fexofenadine) backed by the FDA for non-prescription use in 2011 following the loss of patent exclusivity.
-
Advertising pains
Lachlan James, digital strategy director at BD Network, tells us where healthcare ads hurt
-
S-A's Allegra to be OTC
Sanofi-aventis (S-A) has won approval from the US Food and Drug Administration to market its best-selling allergy drug Allegra (fexofenadine) as an over-the-counter (OTC) medicine in
-
Sanofi-aventis to buy Chattem for $1.9bn
The French drugmaker plans to convert Allegra (fexofenadine) to an OTC product.
More from news
Approximately 1 fully matching, plus 7 partially matching documents found.
Subscribe to our email news alerts
- New Playbook Alert: Virtual Patient Engagement
- AbbVie to expand solid tumour portfolio with $10bn ImmunoGen acquisition
- UK Biobank reveals new data from world's largest genetic project
- New study finds dose of Mavenclad treatment could predict MS relapse risk
- Astellas shares positive 24-week results for non-hormonal menopause drug fezolinetant
- GSK global survey reveals misunderstandings about shingles in adults
No results were found
PMHub
Oxford University Press
Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...
Latest intelligence
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
